why choose us

First received: November 01, 2024

Clinical Trial: Evaluating the Efficacy and Safety of Roflumilast in Patients with NASH

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Non-Alcoholic Steatohepatitis (NASH)

Study Type: INTERVENTIONAL


Official Title: Efficacy and Safety of Roflumilast in Patients with Non-Alcoholic Steatohepatitis

Brief Summary: Study type :clinical trial Main purpose :esnsure safety and efficacy of Roflumilast to treat patients with Non-Alcoholic Steatohepatitis Background and aim: Non-alcoholic fatty liver disease is the most prevalent chronic liver disease globally.There is no defined therapy for non-alcholic steatohepatitis (NASH), therefore this study aimed at evaluating the efficacy and safety of Roflumilast in patients with non-alcoholic NASH.Methods: This randomized controlled parallel study involved 55 patients with NASH who were…

Read more